Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edaravone dexborneol for acute ischemic stroke
NCT06645522Phase 4Not yet recruiting
- Start
- Oct 2024
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of edaravone dexborneol in ischemic stroke. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
edaravone dexborneol
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06645522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06645522.